Our mission is to improve the lives of people living with genetic disease and cancer through research. Vision Image "The mission of the Institute of Genetics and Cancer is to understand development and disease by using the latest approaches in genetic, genomic, cellular and clinical science. Our focus is on research into human genetics and cancer, and on training the next generation in an outstanding environment for basic discovery science and translation." Professor Margaret Frame FRSE FMedSci, Director of the Institute of Genetics and Cancer at the University of EdinburghThe Institute constitutes one of the largest aggregates of human molecular genetics and biology research capacity in the UK with more than 70 Principal Investigators, 500 staff and 100 PhD students. By pooling resources and multidisciplinary skills, the Institute brings together the scientific expertise, technology and support services needed to maximise scientific discovery. Our Institute expertise and facilities enable rapid translation of basic scientific discoveries into new treatments, clinical guidelines and innovative products that have significant impact on society in the UK and worldwide.GovernanceThe Institute constitutes an integral part of the University of Edinburgh, and its activity is overseen by the Institute Director (Professor Margaret Frame), supported by the Institute Executive Group to ensure effective management and oversight: Executive GroupMeets monthly and monitors the delivery of strategic plans and oversees the day-to-day management of the Institute.Membership:Margaret FrameDirector, Institute of Genetics and CancerWendy BickmoreDirector, MRC Human Genetics UnitCharlie GourleyClinical Director, CRUK Scotland CentreNeil CarragherDirector of Science, Edinburgh Cancer ResearchTim AitmanDirector, Centre for Genomic & Experimental MedicineAngela IngramOperations ManagerStephen LissamanChief Operations OfficerHelen NickersonScience and Strategy ManagerThe Executive Group is supported by a number of sub-committees.Major FundersCancer Research UK, as part of the CRUK Scotland Centre and Brain Tumour Centre of Excellence Medical Research Council, which funds the MRC Human Genetics Unit Scottish Higher Education Funding Council, with substantial contributions to the University’s submission to Unit of Assessment 1 (Clinical Medicine) in the most recent national assessment of research excellence This article was published on 2024-09-23